Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
360Perspective Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to FERNANDEZ, SUSAN EMILY, who serves as the busiest examiner for the portfolio. The concentration of the portfolio in 1 distinct art unit suggests a highly focused prosecution strategy.
The workload is handled by a distinct examiner, making this individual the primary point of contact for the company's pending intellectual property. This centralized arrangement means that all current prosecution results depend on the review of a single examiner and art unit. FERNANDEZ, SUSAN EMILY is the sole official managing the company's active docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, SUSAN EMILY | 1 | 52.3% | +60.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19001562 | LACTICASEIBACILLUS RHAMNOSUS ICL-46 STRAIN DERIVED FROM OAT AND ITS USE FOR ANTI-INFLAMMATION, ANTI-ALLERGY, SKIN IMMUNITY ENHANCEMENT, ATOPIC DERMATITIS IMPROVEMENT, SKIN SOOTHING, AND SKIN MICROORGANISM REGULATION | FERNANDEZ, SUSAN EMILY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19001562 | LACTICASEIBACILLUS RHAMNOSUS ICL-46 STRAIN DERIVED FROM OAT AND ITS USE FOR ANTI-INFLAMMATION, ANTI-ALLERGY, SKIN IMMUNITY ENHANCEMENT, ATOPIC DERMATITIS IMPROVEMENT, SKIN SOOTHING, AND SKIN MICROORGANISM REGULATION | FERNANDEZ, SUSAN EMILY | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19001562 | LACTICASEIBACILLUS RHAMNOSUS ICL-46 STRAIN DERIVED FROM OAT AND ITS USE FOR ANTI-INFLAMMATION, ANTI-ALLERGY, SKIN IMMUNITY ENHANCEMENT, ATOPIC DERMATITIS IMPROVEMENT, SKIN SOOTHING, AND SKIN MICROORGANISM REGULATION | FERNANDEZ, SUSAN EMILY | 1651 | §101§103§112 | Non-Final OA | — | Pending | Dec 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial360Perspective Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Susan Emily Fernandez has the most, with 1 of 360Perspective Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
